We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

WONDFO

Wondfo is a high-tech biological company focusing providing professional products and services for rapid diagnosis an... read more Featured Products: More products

Download Mobile App





Wondfo Presents Advanced Solutions in CLIA Testing and Blood Gas Analysis

By LabMedica International staff writers
Posted on 13 Nov 2024
Print article
Image: Wondfo’s innovative products and diagnostic solutions can be experienced at MEDICA 2024 (Photo courtesy of Wondfo)
Image: Wondfo’s innovative products and diagnostic solutions can be experienced at MEDICA 2024 (Photo courtesy of Wondfo)

Wondfo (Guangzhou, China) is presenting a variety of new products at MEDICA 2024, including its new FC-2100 fully automatic chemiluminescence immunoassay analyzer, the Finecare FIA Meter X1 and X2 fluorescence immunoassay analyzer, and the Ucare-6000 automatic blood gas analyzer.

With its precision and efficiency, FC-2100 is attracting a lot of attention at this year’s MEDICA. As a desktop fully-automatic chemiluminescence immunoassay analyzer, it only covers 0.64 sqm, which is more flexible and convenient and can be installed and placed in almost all laboratory operating tables. It has a test speed of up to 200T/hour and shows the first result within 12 minutes. Wondfo’s new immunofluorescence platform, Finecare X Series-FS-1000 & FS-2000, is accurate, efficient, and easy to use. Its motto is “One-Step Operation, Always One Step Ahead.” The X series supports whole blood sample testing. Taking into account the different needs of labs, this new platform offers single-channel (X1) and multi-channels (X2) for options. Its hs-cTnI sensitivity of 20pg/ml enables labs to provide more effective support for acute and critical diseases. Wondfo is also showcasing its colloidal gold Strep A Test Kit which is available for both self-testing and professional use. The Wondfo One Step Strep A Swab Test is a rapid chromatographic immunoassay for the qualitative detection of group A streptococcal antigen from throat swab specimens and is intended for use as an aid in the diagnosis of group A streptococcal infection.

Visitors to the Wondfo booth are also showing great interest in the Ucare-6000 automatic blood gas analyzer which enjoys efficiency, flexibility, and simplified operation. The integration of the electrode cartridge with the reagent bag simplifies the testing operation to one-step sample loading and reduces the cost of individual test cartridges. The Ucare-6000 features an expansive menu comprising 34 parameters of blood gas, electrolytes, metabolites, and Hct, and features a built-in battery that allows 6-hour standby. In addition, Wondfo is highlighting the PA-3600 fully automated IHC staining system that has been independently developed by the company. The PA-3600 is suitable for a wide range of sample types, and can automatically complete the entire process of immunohistochemical staining from baking to re-staining. Since its official launch in 2021, it has been widely used in hospitals, research institutes, ICLs (Independent Clinical Laboratory), pharmaceutical CROs, and other organizations, and has gained recognition for its excellent performance and quality.

Related Links:
Wondfo

Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Mycoplasma Pneumoniae Virus Test
Mycoplasma Pneumoniae Virus Detection Kit
New
Silver Member
Verification Panels for Assay Development & QC
Seroconversion Panels

Print article

Channels

Clinical Chemistry

view channel
Image: The study demonstrated that electric-field molecular fingerprinting can probe cancer (Photo courtesy of ACS Central Science, 2025, 10.1021/acscentsci.4c02164)

New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma

Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read more

Molecular Diagnostics

view channel
Image: The study validated the Lumipulse p-tau21 automated and scalable blood test system (Photo courtesy of Fujirebio)

Blood Test for Early Alzheimer's Detection Achieves Over 90% Accuracy

Alzheimer's disease (AD) is a debilitating condition and a leading cause of disability and death worldwide. The availability of reliable diagnostic tools is currently restricted, and diagnosis often relies... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.